Cargando…
MiR‐22 modulates the expression of lipogenesis‐related genes and promotes hepatic steatosis in vitro
Nonalcoholic fatty liver disease (NAFLD) is highly correlated with obesity, and lifestyle changes to reduce weight remain the main therapeutic approach. The noncoding RNA miR‐22 has previously been reported to be highly abundant in the sera of NAFLD patients. In addition, miR‐22 directly targets per...
Autores principales: | Yang, Zhuo, Qin, Wen, Huo, Junsheng, Zhuo, Qin, Wang, Jingbo, Wang, Liyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780092/ https://www.ncbi.nlm.nih.gov/pubmed/33159388 http://dx.doi.org/10.1002/2211-5463.13026 |
Ejemplares similares
-
Effect Assessment of Aurantio-Obtusin on Novel Human Renal Glomerular Endothelial Cells Model Using a Microfluidic Chip
por: Qin, Wen, et al.
Publicado: (2022) -
miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction
por: Hu, Ying, et al.
Publicado: (2020) -
IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis
por: Negrin, Kimberly A., et al.
Publicado: (2014) -
Modulation of liver steatosis by miR-21/PPARα
por: Rodrigues, Pedro M., et al.
Publicado: (2018) -
Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice
por: Kong, Qin, et al.
Publicado: (2016)